To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
OctoPlus Wins Drug Development and Manufacturing Contract from Danish Pharmaceutical Company
OctoPlus N.V. has announced that a process development and manufacturing contract has been signed with a pharmaceutical company headquartered in Denmark.
The undisclosed contract value will make a material contribution to OctoPlus' annual revenues.
Under the contract terms, we will perform process development and manufacturing of a microsphere-based formulation for our client.
At OctoPlus we provide formulation development and clinical material manufacturing services to biotech and pharmaceutical companies worldwide.
In addition to our expertise in formulation and manufacturing, we offer our clients drug delivery technologies for the development of controlled release versions of existing or new drugs.
